BLACK BOX WARNING: GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome Type 2
New Patterns Emerging Online Among the less typical symptoms discussed: * Around 17% of users reported fatigue * About 4% mentioned menstrual irregularities, such as changes in cycle or bleeding * Between 1% and 4% described sensitivity to temperature, including chills or hot flashes Researchers say these findings highlight real-world patient experiences that may not always be fully reflected in controlled trials
Date, time, units drawn, concentration, milligrams administered, injection site
Analytical testing methods are employed to evaluate peptide identity and overall purity before release
People want to lose weight for beauty and a quick fix